Skip to main content
. 2016 Nov 16;7(52):86339–86349. doi: 10.18632/oncotarget.13404

Table 2. Multivariate analysis (Cox regression) including clinical and pathological parameters in addition to 18q deletion in all cancers, ERG negative cancers and ERG positive cancers.

Tumor subset Scenario n analyzable P value
preop. PSA-Level pT Stage cT Stage Gleason grade prostatectomy Gleason grade biopsy pN Stage R-Status 18q Deletion
all cancers 1 3819 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.0097 0.0004
2 6126 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.0004
3 6008 < 0.0001 < 0.0001 < 0.0001 0.0001
4 5925 < 0.0001 < 0.0001 < 0.0001 < 0.0001
ERG-negative cancers 1 1916 < 0.0001 < 0.0001 < 0.0001 0.0001 0.0749 0.0148
2 3030 < 0.0001 < 0.0001 < 0.0001 0.0024 0.0157
3 2988 < 0.0001 < 0.0001 < 0.0001 0.0067
4 2949 < 0.0001 < 0.0001 < 0.0001 0.0024
ERG-positive cancers 1 1674 0.0282 < 0.0001 < 0.0001 0.0355 0.1069 0.0264
2 2666 0.0009 < 0.0001 < 0.0001 0.0015 0.0634
3 2598 < 0.0001 < 0.0001 < 0.0001 0.0335
4 2560 < 0.0001 < 0.0001 < 0.0001 0.0593